""

Gliomas (grade I-III)

Recruiting after consultation
Open recruiting

Neoadjuvant Therapy

There are currently no studies available

Adjuvant Therapy

There are currently no studies available

Surgical Study

There are currently no studies available

Radiotherapy Study

Title: Prospective Phase II Trial to Assess Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma Multicentric, Prospective Interventional, Randomized, Observer Blind Two Arm (Active Control), Parallel Group Investigator-initiated Phase II Trial
Phase: II
Contact: Studienambulanz Strahlentherapie / Kontaktperson
Clinical Investigator: Dr. med. Semi Harrabi
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05964569
EudraCT-Number: Keine Registernummer angegeben.

Metastatic Disease: First-Line-Therapy

Title: ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study
Phase: III
Contact: Tanja Haut / Kontaktperson
Clinical Investigator: PD Dr. med. Antje Wick
Registration: Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe NCT05580562
EudraCT-Number: Siehe EU klinisches Studienregister 2022-502051-56-00

Metastatic Disease: Follow-Up Treatment

There are currently no studies available

Other study

There are currently no studies available